Related references
Note: Only part of the references are listed.A call to strengthen the global strategy against schistosomiasis and soil-transmitted helminthiasis: the time is now
Nathan C. Lo et al.
LANCET INFECTIOUS DISEASES (2017)
The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread
Charles J. Woodrow et al.
FEMS MICROBIOLOGY REVIEWS (2017)
Repositioning of chlorambucil as a potential anti-schistosomal agent
Maha M. Eissa et al.
ACTA TROPICA (2017)
Clinical implications of recent findings in schistosome proteomics
Patrick Driguez et al.
EXPERT REVIEW OF PROTEOMICS (2016)
Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni
Riham M. El-Moslemany et al.
ACTA TROPICA (2016)
Prophylactic effect of artemether on human schistosomiasis mansoni among Egyptian children: A randomized controlled trial
Hala Elmorshedy et al.
ACTA TROPICA (2016)
Discovery of Antischistosomal Drug Leads Based on Tetraazamacrocyclic Derivatives and Their Metal Complexes
M. O. Faruk Khan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Revisiting the SAR of the Antischistosomal Aryl Hydantoin (Ro 13-3978)
Chunkai Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Nicholas J. Kassebaum et al.
LANCET (2016)
Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial
Remigio M. Olveda et al.
LANCET INFECTIOUS DISEASES (2016)
Praziquantel coverage in schools and communities targeted for the elimination of urogenital schistosomiasis in Zanzibar: a cross-sectional survey
Stefanie Knopp et al.
PARASITES & VECTORS (2016)
Schistosomiasis vaccines: where do we stand?
Biniam Mathewos Tebeje et al.
PARASITES & VECTORS (2016)
Antischistosomal activity of artemisinin derivatives in vivo and in patients
Mohamed E. M. Saeed et al.
PHARMACOLOGICAL RESEARCH (2016)
Global Assessment of Schistosomiasis Control Over the Past Century Shows Targeting the Snail Intermediate Host Works Best
Susanne H. Sokolow et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems
Alessandra Guidi et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis
Amaya L. Bustinduy et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial
Beatrice Barda et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Efficacy of Synriam™, a new antimalarial combination of OZ277 and piperaquine, against different developmental stages of Schistosoma mansoni
Shereen F. Mossallam et al.
ACTA TROPICA (2015)
Efficacy and Safety of Arachidonic Acid for Treatment of School-Age Children in Schistosoma mansoni High-Endemicity Regions
Rashida Barakat et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2015)
Activities of N,N′-Diarylurea MMV665852 Analogs against Schistosoma mansoni
Noemi Cowan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Elucidation of the in vitro and in vivo activities of bridged 1,2,4-trioxolanes, bridged 1,2,4,5-tetraoxanes, tricyclic monoperoxides, silyl peroxides, and hydroxylamine derivatives against Schistosoma mansoni
Noemi Cowan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Target-based molecular modeling strategies for schistosomiasis drug discovery
Leonardo G. Ferreira et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Re-positioning protein-kinase inhibitors against schistosomiasis
Verena Gelmedin et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Natural products with antischistosomal activity
Josue de Moraes
FUTURE MEDICINAL CHEMISTRY (2015)
Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa: a systematic review and geostatistical analysis
Ying-Si Lai et al.
LANCET INFECTIOUS DISEASES (2015)
Natural Products as Leads in Schistosome Drug Discovery
Bruno J. Neves et al.
MOLECULES (2015)
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Noemi Cowan et al.
PARASITES & VECTORS (2015)
Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni
Gordana Panic et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Nobel prize for the artemisinin and ivermectin discoveries: a great boost towards elimination of the global infectious diseases of poverty
Ernest Tambo et al.
INFECTIOUS DISEASES OF POVERTY (2015)
Predictive risk mapping of schistosomiasis in Brazil using Bayesian geostatistical models
Ronaldo G. C. Scholte et al.
ACTA TROPICA (2014)
Efficacy and Safety of Arachidonic Acid for Treatment of Schistosoma mansoni-Infected Children in Menoufiya, Egypt
Sahar Selim et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2014)
Synthesis and activity of new triphenylphosphonium derivatives of betulin and betulinic acid against Schistosoma mansoni in vitro and in vivo
Anna Yu. Spivak et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Artemisinin Combination Therapies and Malaria Parasite Drug Resistance: The Game Is Afoot
Steve M. Taylor et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
In vitro and in vivo antischistosomal activity of ferroquine derivatives
Jennifer Keiser et al.
PARASITES & VECTORS (2014)
The Global Burden of Disease Study 2010: Interpretation and Implications for the Neglected Tropical Diseases
Peter J. Hotez et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Praziquantel, Mefloquine-Praziquantel, and Mefloquine-Artesunate-Praziquantel against Schistosoma haematobium: A Randomized, Exploratory, Open-Label Trial
Jennifer Keiser et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
A Randomized, Single-Ascending-Dose, Ivermectin-Controlled, Double-Blind Study of Moxidectin in Onchocerca volvulus Infection
Kwablah Awadzi et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Orally Active Antischistosomal Early Leads Identified from the Open Access Malaria Box
Katrin Ingram-Sieber et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Repurposing drugs for the treatment and control of helminth infections
Gordana Panic et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2014)
Fixed dose combination of arterolane and piperaquine: A newer prospect in antimalarial therapy
C. Y. Patil et al.
ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH (2014)
Time to set the agenda for schistosomiasis elimination
David Rollinson et al.
ACTA TROPICA (2013)
Diagnosis and treatment of schistosomiasis in children in the era of intensified control
Stefanie Knopp et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment
Belen Pedrique et al.
LANCET GLOBAL HEALTH (2013)
In Vivo Activity of Aryl Ozonides against Schistosoma Species
Jennifer Keiser et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Antischistosomal Activities of Mefloquine-Related Aryhnethanols
Katrin Ingram et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Schistosomiasis
Bruno Gryseels
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2012)
Medicinal Plants: A Source of Anti-Parasitic Secondary Metabolites
Michael Wink
MOLECULES (2012)
Whole-genome sequence of Schistosoma haematobium
Neil D. Young et al.
NATURE GENETICS (2012)
Systematic Review and Meta-Analysis of Artemisinin Based Therapies for the Treatment and Prevention of Schistosomiasis
Luis Perez del Villar et al.
PLOS ONE (2012)
Effectiveness of a comprehensive schistosomiasis japonica control program in Jiangsu province, China, from 2005 to 2008
Qing-biao Hong et al.
ACTA TROPICA (2011)
From innovation to application: Social-ecological context, diagnostics, drugs and integrated control of schistosomiasis
Juerg Utzinger et al.
ACTA TROPICA (2011)
Trioxaquine PA1259 Alkylates Heme in the Blood-Feeding Parasite Schistosoma mansoni
Vincent Pradines et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Chemistry and Pharmacology of Neglected Helminthic Diseases
A. Muellner et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum
Connor O'Brien et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
Schistosoma mansoni: Antischistosomal activity of the four optical isomers and the two racemates of mefloquine on schistosomula and adult worms in vitro and in vivo
Theresia Manneck et al.
EXPERIMENTAL PARASITOLOGY (2011)
Miltefosine, a promising novel agent for schistosomiasis mansoni
Maha M. Eissa et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2011)
Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro
Jennifer Keiser et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Efficacy and Safety of Mefloquine, Artesunate, Mefloquine-Artesunate, and Praziquantel against Schistosoma haematobium: Randomized, Exploratory Open-Label Trial
Jennifer Keiser et al.
CLINICAL INFECTIOUS DISEASES (2010)
Activity of antiandrogens against juvenile and adult Schistosoma mansoni in mice
Jennifer Keiser et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
ACTs for schistosomiasis: do they act?
Jurg Utzinger et al.
LANCET INFECTIOUS DISEASES (2010)
The position of mefloquine as a 21st century malaria chemoprophylaxis
Patricia Schlagenhauf et al.
MALARIA JOURNAL (2010)
In vitro and in vivo trematode models for chemotherapeutic studies
J. Keiser
PARASITOLOGY (2010)
Schistosome genomes: a wealth of information
Joanne P. Webster et al.
TRENDS IN PARASITOLOGY (2010)
In Vitro Activities of Trioxaquines against Schistosoma mansoni
Jerome Boissier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
The genome of the blood fluke Schistosoma mansoni
Matthew Berriman et al.
NATURE (2009)
Effect of single-dose oral mefloquine on the morphology of adult Schistosoma japonicum in mice
Shu-Hua Xiao et al.
PARASITOLOGY RESEARCH (2009)
Reduced Susceptibility to Praziquantel among Naturally Occurring Kenyan Isolates of Schistosoma mansoni
Sandra D. Melman et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Mefloquine-An Aminoalcohol with Promising Antischistosomal Properties in Mice
Jennifer Keiser et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Drug Discovery for Schistosomiasis: Hit and Lead Compounds Identified in a Library of Known Drugs by Medium-Throughput Phenotypic Screening
Maha-Hamadien Abdulla et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Hybrid molecules with a dual mode of action: Dream or reality?
Bernard Meunier
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis
Michael J. Doenhoff et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2008)
Qinghaosu (Artemisinin): The price of success
N. J. White
SCIENCE (2008)
Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice
Luc Van Nassauw et al.
Travel Medicine and Infectious Disease (2008)
Trick or Treat: The Role of Vaccines in Integrated Schistosomiasis Control
Robert Bergquist et al.
PLOS NEGLECTED TROPICAL DISEASES (2008)
The unacknowledged impact of chronic schistosomiasis
Charles H. King et al.
CHRONIC ILLNESS (2008)
Artemisinins and synthetic trioxolanes in the treatment of helminth infections
Jennifer Keiser et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2007)
In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species
Shu-Hua Xiao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Rapid-impact interventions: How a policy of integrated control for Africa's neglected tropical diseases could benefit the poor
DH Molyneux et al.
PLOS MEDICINE (2005)
Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis
CH King et al.
LANCET (2005)
Drugs for the control of parasitic diseases: current status and development in schistosomiasis
A Fenwick et al.
TRENDS IN PARASITOLOGY (2003)
Schistosoma intercalatum:: an endangered species in Cameroon?
LAT Tchuenté et al.
TRENDS IN PARASITOLOGY (2003)
Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa
MJ van der Werf et al.
ACTA TROPICA (2003)
Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice
J Utzinger et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2002)
Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites
J Utzinger et al.
CURRENT MEDICINAL CHEMISTRY (2001)
Artesunate and praziquantel for the treatment of Schistosoma haematobium infections:: A double-blind, randomized, placebo-controlled study
S Borrmann et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Oral artemether for prevention of Schistosoma mansoni infection:: randomised controlled trial
J Utzinger et al.
LANCET (2000)
Drug resistance in human helminths: Current situation and lessons from livestock
S Geerts et al.
CLINICAL MICROBIOLOGY REVIEWS (2000)